{
  "id": "3058ea568a62cd3a",
  "title": "FDA Approves New Regimen for Cisplatin - Ineligible MIBC Patients",
  "description": "20251217T144500Z",
  "content": "",
  "source": "cancertherapyadvisor.com",
  "source_url": "https://www.cancertherapyadvisor.com/news/fda-approves-new-regimen-for-cisplatin-ineligible-mibc-patients/",
  "published_at": "20251217T144500Z",
  "fetched_at": "2025-12-18T00:22:47.263985+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.cancertherapyadvisor.com/news/fda-approves-new-regimen-for-cisplatin-ineligible-mibc-patients/",
    "url_mobile": "",
    "title": "FDA Approves New Regimen for Cisplatin - Ineligible MIBC Patients",
    "seendate": "20251217T144500Z",
    "socialimage": "https://www.cancertherapyadvisor.com/wp-content/uploads/sites/12/2024/01/CTA_1200x675.png",
    "domain": "cancertherapyadvisor.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}